speaker-info

Sylvaine Cases

Sr Director, Head of External Science & Partnering US West, Sanofi, Strategy & Business Development

The Sanofi External Science & Partnering within Sanofi global business development organization is distributed in the major hubs of innovation and is charged with cultivating geographical ecosystems to uncover and manage early stage deal opportunities of interest to the global therapeutic areas to build their pipelines through external innovation. Sylvaine is heading External Science & partnering for Sanofi in Western US and Canada. In this geography, her team supports the implementation of Sanofi external innovation strategy and manages opportunity review, assessment of scientific risk and opportunities, and the stage deal process.  Prior to joining Sanofi in 2010, Sylvaine has been working for 16 years in the San Francisco Bay area in academia and biotechnology and her experience covers basic research as well as drug discovery and pre-clinical research and development in oncology and metabolic disorders. She completed post-doctoral studies at the Gladstone Institutes/UCSF, where she discovered new enzyme families in the pathways of lipid synthesis and storage. She then held an academic appointment at the Gladstone Institutes, where she focused on lipid metabolism in obesity and cancer. Most recently she was responsible for Translational Oncology and led early drug discovery projects at Cytokinetics, and was Head of Pharmacology at Arete Therapeutics.
Sylvaine Cases received a MS in biochemistry from the French engineering school AgroParisTech in Paris, and a Ph.D. in Molecular Oncology from the University of Paris 7 and Institut Gustave Roussy.

Panel Discussion: What’s Next in Innovative Healthcare Technologies – Investors’ Perspectives

The Golden Gate Club

In this panel discussion, prominent healthcare investors from pharmaceutical companies, venture capital firms, incubators, and funding agencies, will share their visions on what’s next in innovative healthcare technologies, and their investment strategies to capture such opportunities.

READ MORE